Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Atopic dermatitis burden scale: creation of a specific burden questionnaire for families.

Méni C, Bodemer C, Toulon A, Merhand S, Perez-Cullell N, Branchoux S, Taieb C.

J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1426-32. doi: 10.1111/jdv.12180. Epub 2013 May 16.

PMID:
23675975
2.

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.

Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, Toubiana J, Itan Y, Audry M, Nitschke P, Masson C, Toth B, Flatot J, Migaud M, Chrabieh M, Kochetkov T, Bolze A, Borghesi A, Toulon A, Hiller J, Eyerich S, Eyerich K, Gulácsy V, Chernyshova L, Chernyshov V, Bondarenko A, Grimaldo RM, Blancas-Galicia L, Beas IM, Roesler J, Magdorf K, Engelhard D, Thumerelle C, Burgel PR, Hoernes M, Drexel B, Seger R, Kusuma T, Jansson AF, Sawalle-Belohradsky J, Belohradsky B, Jouanguy E, Bustamante J, Bué M, Karin N, Wildbaum G, Bodemer C, Lortholary O, Fischer A, Blanche S, Al-Muhsen S, Reichenbach J, Kobayashi M, Rosales FE, Lozano CT, Kilic SS, Oleastro M, Etzioni A, Traidl-Hoffmann C, Renner ED, Abel L, Picard C, Maródi L, Boisson-Dupuis S, Puel A, Casanova JL.

J Exp Med. 2011 Aug 1;208(8):1635-48. doi: 10.1084/jem.20110958. Epub 2011 Jul 4.

3.

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.

Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL.

Science. 2011 Apr 1;332(6025):65-8. doi: 10.1126/science.1200439. Epub 2011 Feb 24.

4.

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.

Puel A, Döffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, Cobat A, Ouachée-Chardin M, Toulon A, Bustamante J, Al-Muhsen S, Al-Owain M, Arkwright PD, Costigan C, McConnell V, Cant AJ, Abinun M, Polak M, Bougnères PF, Kumararatne D, Marodi L, Nahum A, Roifman C, Blanche S, Fischer A, Bodemer C, Abel L, Lilic D, Casanova JL.

J Exp Med. 2010 Feb 15;207(2):291-7. doi: 10.1084/jem.20091983. Epub 2010 Feb 1.

5.

A role for human skin-resident T cells in wound healing.

Toulon A, Breton L, Taylor KR, Tenenhaus M, Bhavsar D, Lanigan C, Rudolph R, Jameson J, Havran WL.

J Exp Med. 2009 Apr 13;206(4):743-50. doi: 10.1084/jem.20081787. Epub 2009 Mar 23.

6.

Washington State's initiative to disseminate and implement high-fidelity ACT teams.

Bjorklund RW, Monroe-Devita M, Reed D, Toulon A, Morse G.

Psychiatr Serv. 2009 Jan;60(1):24-7. doi: 10.1176/appi.ps.60.1.24.

PMID:
19114566
7.

Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia.

Sainte Marie Y, Toulon A, Paus R, Maubec E, Cherfa A, Grossin M, Descamps V, Clemessy M, Gasc JM, Peuchmaur M, Glick A, Farman N, Jaisser F.

Am J Pathol. 2007 Sep;171(3):846-60. Epub 2007 Aug 3.

8.

Wells' syndrome after primoinfection by parvovirus B19 in a child.

Toulon A, Bourdon-Lanoy E, Hamel D, Fraitag S, Leruez-Ville M, de Prost Y, Hadj-Rabia S.

J Am Acad Dermatol. 2007 Feb;56(2 Suppl):S50-1. No abstract available.

PMID:
17224386
9.

Acitretin-induced erythroderma in a psoriatic patient.

Mahé E, Descamps V, Baïkian B, Toulon A, Crickx B.

J Eur Acad Dermatol Venereol. 2006 Oct;20(9):1133-4. No abstract available.

PMID:
16987272
10.

Preliminary clinical studies of a biological skin equivalent in burned patients.

Wassermann D, Schlotterer M, Toulon A, Cazalet C, Marien M, Cherruau B, Jaffray P.

Burns Incl Therm Inj. 1988 Aug;14(4):326-30.

PMID:
3066451

Supplemental Content

Loading ...
Support Center